Xellia Pharmaceuticals Competitors and Similar CompaniesClear all

Xellia Pharmaceuticals's competitors and similar companies include Genentech, Cipla and Mankind Pharma.

	Xellia Pharmaceuticals Xellia Pharmaceuticals is a company focused on providing anti-infective treatments against life-threatening infections.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 1903	Founding Date 1976	Founding Date 1935	Founding Date 1995
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Copenhagen, DK HQ Shanghai, CN Taizhou, CN Zagreb, HR Budapest, HU Bengaluru, IN Oslo, NO see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ
Employees	Employees 45317% decrease	Employees 18,077	Employees 27,764	Employees 16,2532% increase
Financial
Revenue (est.)	Revenue (est.) kr1.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods kr1.1b (FY, 2025)	Cost of goods N/A	Cost of goods ₹97.2b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit kr314.9m (FY, 2025)	Gross profit N/A	Gross profit ₹184.4b (FY, 2026)	Gross profit N/A
Net income	Net income kr213.7m (FY, 2025)	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income N/A